Trial NCT01290601

View at ClinicalTrials.gov 
Org. Study IDs: TQ study 058
Secondary IDs: A-12055

Last trial update was posted on 2018-02-23

MeSH Interventions

Chloroquine Chloroquine diphosphate Primaquine Tafenoquine

MeSH Conditions

Malaria

Other Conditions

Plasmodium Vivax

Stopping Reasons

Failure to meet pre-specified endpoint for the day 28 cure rate

Limitations And Caveats

IDMC determined that Cohort 1 failed to meet specified endpoint for d28 cure rate; Cohort 2 wasn't initiated and follow-up in Cohort 1 should be completed according to protocol. Following last subjects last visit for Cohort 1 study was terminated.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID